Dr. Michael Schumacher is a gastrointestinal physiologist focused on discovering new therapeutic targets for inflammatory bowel disease (IBD) including ulcerative colitis and Crohn’s disease. Dr. Schumacher's lab studies how intestinal tissues interpret, respond to, and recover from inflammation, with a particular emphasis on how immune signals shape epithelial function, tissue remodeling, and mucosal healing.
Home Department: Chemical Engineering
Faculty Advisor: Christina Smolke
Talk Title: Production of Plant Alkaloids in Saccharomyces Cerevisiae
Event: American Institute of Chemical Engineers Annual Meeting 2013
Home Department: Computer Science
Faculty Advisors: Anshul Kundaje and Michael Bassik
Talk Title: Transcriptome-wide association studies are vulnerable to false positives due to co-regulation
Event: American Society of Human Genetics 2017 Annual Meeting
